As of 2026-01-07, the Relative Valuation of Veracyte Inc (VCYT) is 7.66 USD. This relative valuation is based on P/E multiples. With the latest stock price at 45.64 USD, the upside of Veracyte Inc based on Relative Valuation is -83.2%.
The range of the Relative Valuation is 6.36 - 13.67 USD.
| Range | Selected | |
| Trailing P/E multiples | 16.7x - 22.4x | 17.8x |
| Forward P/E multiples | 16.7x - 29.0x | 18.1x |
| Fair Price | 6.36 - 13.67 | 7.66 |
| Upside | -86.1% - -70.1% | -83.2% |
| Date | P/E |
| 2026-01-02 | 111.03 |
| 2025-12-31 | 110.27 |
| 2025-12-30 | 110.74 |
| 2025-12-29 | 112.31 |
| 2025-12-26 | 111.29 |
| 2025-12-24 | 112.03 |
| 2025-12-23 | 112.42 |
| 2025-12-22 | 112.86 |
| 2025-12-19 | 112.42 |
| 2025-12-18 | 110.11 |
| 2025-12-17 | 110.56 |
| 2025-12-16 | 113.21 |
| 2025-12-15 | 114.02 |
| 2025-12-12 | 112.21 |
| 2025-12-11 | 110.59 |
| 2025-12-10 | 113.49 |
| 2025-12-09 | 114.83 |
| 2025-12-08 | 116.19 |
| 2025-12-05 | 116.85 |
| 2025-12-04 | 124.18 |
| 2025-12-03 | 125.07 |
| 2025-12-02 | 120.91 |
| 2025-12-01 | 121.51 |
| 2025-11-28 | 124.00 |
| 2025-11-26 | 124.97 |
| 2025-11-25 | 129.34 |
| 2025-11-24 | 122.32 |
| 2025-11-21 | 115.27 |
| 2025-11-20 | 107.00 |
| 2025-11-19 | 104.59 |
| 2025-11-18 | 101.52 |
| 2025-11-17 | 102.89 |
| 2025-11-14 | 103.07 |
| 2025-11-13 | 104.43 |
| 2025-11-12 | 110.80 |
| 2025-11-11 | 111.74 |
| 2025-11-10 | 110.93 |
| 2025-11-07 | 109.22 |
| 2025-11-06 | 109.20 |
| 2025-11-05 | 120.59 |
| 2025-11-04 | 94.61 |
| 2025-11-03 | 95.47 |
| 2025-10-31 | 94.50 |
| 2025-10-30 | 92.54 |
| 2025-10-29 | 92.75 |
| 2025-10-28 | 93.25 |
| 2025-10-27 | 94.22 |
| 2025-10-24 | 96.21 |
| 2025-10-23 | 93.35 |
| 2025-10-22 | 91.02 |